EP2167038
USE OF TACI-IG FUSION PROTEIN SUCH AS ATACICEPT FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING LUPUS ERYTHEMATOSUS
:
EP einkaleyfi: Þýðing ekki lögð inn:
13.6.2008:
25.4.2018:
08771043.0
:
12.6.2028
:
USE OF TACI-IG FUSION PROTEIN SUCH AS ATACICEPT FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING LUPUS ERYTHEMATOSUS
13.6.2008
25.4.2018
:
Zymogenetics, Inc.:
1201 Eastlake Avenue East, 98102, Seattle, WA, US
:
ARES TRADING S.A.:
Zone Industrielle de l'Ouriettaz, 1170, Aubonne, CH
:
BUSBY, Sharon J.:
Seattle, Washington, US
:
GROSS, Jane A.:
Seattle, Washington, US
:
VISICH, Jennifer:
San Francisco, CA, US
:
NESTOROV, Ivan:
Issaguah, Washington, US
:
MUNAFO, Alain:
Tartegnin, CH
:
PAPASOULIOTIS, Orestis:
Geneva, CH
:
PENA ROSSI, Claudia:
Geneva, CH
:
943618 P:
13.6.2007:
US
:
24031:
28.1.2008:
US
:
US2008066945:
13.6.2008
:
A61K 9/06, A61K 9/00, A61K 38/00